Healthcare, Pharma & Life Sciences

STEMREGEN Ranks No. 332 on Inc. 5000 With 1,017% Growth

Image
STEMREGEN Ranks No. 332 on Inc. 5000 With 1,017% Growth

Whitefish, Mont. – September 26, 2026 -- STEMREGEN, a maker of science-backed stem cell supplements, has landed at No. 332 on the 2026 Inc. 5000 list after posting 1,017% revenue growth over three years, far outpacing the list's 130% median.

Company secures third straight Inc. 5000 ranking as growth trajectory accelerates

STEMREGEN previously ranked No. 265 in 2025 and No. 1,765 in 2024, marking three consecutive years on the annual list of America's fastest-growing private companies. The 2026 ranking measures revenue growth from 2022 through 2025.

MAYPHARM Launches HYALMASS AQUATOX, a Five-Active Aesthetic Formula

Image
MAYPHARM Launches HYALMASS AQUATOX, a Five-Active Aesthetic Formula

Seoul – September 26, 2026 -- MAYPHARM has announced the upcoming launch of HYALMASS AQUATOX, a new aesthetic formulation combining five high-interest active ingredients into a single product for the global cosmeceutical market.

MAYPHARM combines five actives into one formulation to meet multifunctional demand

The new product integrates PDRN, Exosomes, Botulinum Peptide, GHK-Cu, and Succinic Acid in one advanced skin solution. Botulinum Peptide is designed to support a smoother skin appearance, while GHK-Cu is studied for skin conditioning and regeneration. Succinic Acid is positioned for antioxidant activity, PDRN for skin regeneration and recovery, and Exosomes for advanced rejuvenation approaches.

MSE Gives MedStar Health $1.1M for D.C. Maternal, Pediatric Care

Image
MSE Gives MedStar Health $1.1M for D.C. Maternal, Pediatric Care

Washington, D.C. – September 26, 2026 -- Monumental Sports & Entertainment (MSE) has donated $1.1 million to MedStar Health, extending a five-year philanthropic commitment first pledged in 2024 to fund maternal, infant and pediatric care programs across Washington, D.C.

MSE and MedStar Health extend a five-year funding pledge into its third year

The gift continues annual support MSE committed in 2024 to expand access to specialized health services for birthing mothers and children in the District. Since 2019, MSE and The Leonsis Family have contributed more than $13 million to MedStar Health initiatives, including pediatric community health, COVID-19 response and sports medicine programs.

N95 Mask Market to Triple to $11.08B by 2034 on Safety Rules

Image
N95 Mask Market to Triple to $11.08B by 2034 on Safety Rules

Pune – – September 26, 2026 -- The global N95 mask market is projected to grow from $3.27 billion in 2025 to $11.08 billion by 2034, a 14.52% compound annual growth rate, according to Maximize Market Research.

North America dominates as major respirator makers expand capacity

North America held the largest regional share in 2025, driven by hospital demand, workplace safety mandates, and infection-control requirements. Manufacturers including 3M, Honeywell, Moldex-Metric, Cardinal Health, and Medline Industries maintain significant production presence in the region, supporting its lead position through continued investment in respiratory-protection capacity.

AI Clinical Trials Market to Hit $7.32B by 2034, 15.5% CAGR

Image
AI Clinical Trials Market to Hit $7.32B by 2034, 15.5% CAGR

Pune, India – September 26, 2026 -- The global AI in Clinical Trials Market is set to more than triple from USD 2 billion in 2025 to USD 7.32 billion by 2034, expanding at a 15.5% compound annual growth rate, according to Maximize Market Research.

Pharmaceutical firms accelerate AI adoption to cut trial delays

Pharmaceutical and biotechnology companies, along with contract research organizations, hospitals and research institutes, are deploying machine learning, natural language processing and deep learning to speed patient screening, cohort selection, trial design and large-scale data analysis. These tools are applied across Phase I, Phase II and Phase III trials for patient recruitment, safety monitoring, drug discovery and personalized medicine.

Clinical Trials Market to Hit $99.4B by 2034 on AI, Decentralized Trial Growth

Image
Clinical Trials Market to Hit $99.4B by 2034 on AI, Decentralized Trial Growth

Pune – September 26, 2026 -- The global clinical trials market reached USD 58.19 billion in 2025 and is forecast to grow at a 6.13% compound annual rate through 2034, reaching USD 99.4 billion, according to Maximize Market Research.

North America retains dominant share on trial infrastructure and R&D spend

North America leads global trial activity, underpinned by extensive pharmaceutical and biotechnology infrastructure, significant cancer research burden, and the presence of major contract research organizations. The United States drives the bulk of regional Phase I-IV trial volume, while Canada contributes through government investment in trial infrastructure. Europe holds a substantial share as well, with the UK, France, Germany, Italy, Spain, Sweden and Austria supporting research across oncology, cardiovascular disease, CNS conditions, diabetes, obesity and autoimmune disorders.

Dietary Supplements Market to Hit $324.88B by 2034, Says MMR

Image
Dietary Supplements Market to Hit $324.88B by 2034, Says MMR

Pune, India – September 26, 2026 -- The global dietary supplements market was valued at USD 186.36 billion in 2025 and is forecast to reach USD 324.88 billion by 2034, expanding at a compound annual growth rate of 6.37% between 2026 and 2034, according to a new report from Maximize Market Research.

North America dominates supplement demand on preventive healthcare spending

North America leads the global market, driven by high consumer spending on health and wellness, strong preventive healthcare awareness, and regulatory clarity that supports major dietary supplement manufacturers. The United States remains the largest contributor within the region, with strong uptake of vitamins, minerals, herbal supplements, probiotics, and sports nutrition products.

NeuroSense Cuts H1 Costs 28%, Targets Dec. 2026 Canada ALS Filing

Image
NeuroSense Cuts H1 Costs 28%, Targets Dec. 2026 Canada ALS Filing

Cambridge, Mass. – September 26, 2026 -- NeuroSense Therapeutics (NASDAQ: NRSN) cut operating expenses to $3.4 million in the first half of 2026, down from $4.7 million a year earlier, as the biotech pushes its ALS candidate PrimeC toward a Canadian regulatory filing targeted for December 2026.

NeuroSense trims R&D and G&A spending by double digits in H1 2026

Research and development expenses fell 16% to $2,102 thousand from $2,503 thousand, driven by lower subcontractor and consultant costs, partly offset by higher share-based payment expense. General and administrative expenses dropped 38.6% to $1,345 thousand from $2,189 thousand on reduced professional services spending.

Sun Life, KC Royals Hit $50,000 Goal for Youth Dental Access

Image
Sun Life, KC Royals Hit $50,000 Goal for Youth Dental Access

Kansas City, Mo. – September 26, 2026 -- Sun Life U.S. and the Kansas City Royals Foundation have completed the first "Every Single Smile" campaign, raising $50,000 to expand dental care access for underserved youth in Kansas City through nonprofit TeamSmile.

Every Royals single triggered a donation toward the season-long fundraising goal

The campaign converted a core baseball statistic into a philanthropic mechanism, with each single hit by the Royals generating a contribution from Sun Life and the Kansas City Royals Foundation over the course of the season.

Funds will finance a new December dental clinic and expand preventive care access

The $50,000 will support an additional TeamSmile dental clinic in Kansas City this December and strengthen the Dental Home Project, which links underserved youth with local dentists for ongoing preventive care relationships.

Saber Healthcare Discloses Ransomware Attack Exposing Patient Data

Beachwood, Ohio – September 26, 2026 -- Saber Healthcare Group has disclosed a cybersecurity incident in which an outside party encrypted a portion of its corporate network files on September 26, 2026, potentially exposing personal and medical information tied to an undisclosed number of individuals.

Attacker encrypted files causing service outage on September 26, 2026

Saber detected a service outage affecting internal and external computer systems on that date. The company secured and isolated its systems and launched an investigation with outside cybersecurity experts, who confirmed an unauthorized party had accessed the corporate network and encrypted a small portion of files, triggering the outage.